Otezla 30 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FTCFE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,013
Award facts
- Contract value 100% obligated
- $6,012.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Otezla 30 mg tablets (60-count units) with a ceiling value of $6,012.91. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 5, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through the DLA's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. This award reflects AmerisourceBergen's ongoing role in supporting federal medical procurement requirements, with the DLA planning future Pharmaceutical Prime Vendor Global Program Generation V contracts potentially involving multiple regional awards to various contractors.
Quick answers
Who was awarded contract SPE2DB26FTCFE?
SPE2DB26FTCFE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FTCFE worth?
The government has obligated $6,013 on SPE2DB26FTCFE.
Is contract SPE2DB26FTCFE an order under another contract?
Yes. SPE2DB26FTCFE is a delivery order under SPE2DB25D3110, an indefinite delivery contract.
Was contract SPE2DB26FTCFE competed?
The extent of competition for SPE2DB26FTCFE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award